These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12361835)

  • 1. Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion?
    McDonald PC; Wilson JE; Gao M; McNeill S; Spinelli JJ; Williams OD; Harji S; Kenyon J; McManus BM
    Cardiovasc Pathol; 2002; 11(5):251-62. PubMed ID: 12361835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion?" by McDonald PC, et all.
    Volmar KE; Hutchins GM
    Cardiovasc Pathol; 2003; 12(3):174; author reply 175. PubMed ID: 12790096
    [No Abstract]   [Full Text] [Related]  

  • 3. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL
    JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operation for anorexigen-associated valvular heart disease.
    Caccitolo JA; Connolly HM; Rubenson DS; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):656-64. PubMed ID: 11581595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valvular heart disease associated with fenfluramine-phentermine.
    Connolly HM; Crary JL; McGoon MD; Hensrud DD; Edwards BS; Edwards WD; Schaff HV
    N Engl J Med; 1997 Aug; 337(9):581-8. PubMed ID: 9271479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 7. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
    Sachdev M; Miller WC; Ryan T; Jollis JG
    Am Heart J; 2002 Dec; 144(6):1065-73. PubMed ID: 12486432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
    JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography.
    Vagelos R; Jacobs M; Popp RL; Liang D
    J Am Soc Echocardiogr; 2002 Jun; 15(6):653-7. PubMed ID: 12050608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic changes in three explanted native cardiac valves following use of fenfluramines.
    Steffee CH; Singh HK; Chitwood WR
    Cardiovasc Pathol; 1999; 8(5):245-53. PubMed ID: 10533956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease.
    Prasad A; Mehra M; Park M; Scott R; Uber PA; McFadden PM
    Ann Thorac Surg; 1999 Nov; 68(5):1840-1. PubMed ID: 10585071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular heart disease with the use of fenfluramine-phentermine.
    Surapaneni P; Vinales KL; Najib MQ; Chaliki HP
    Tex Heart Inst J; 2011; 38(5):581-3. PubMed ID: 22163141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota.
    Kimmel SE; Keane MG; Crary JL; Jones J; Kinman JL; Beare J; Sammel M; Sutton MS; Strom BL
    Am J Cardiol; 1999 Aug; 84(3):304-8. PubMed ID: 10496440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphology of anorexigen-associated valve disease by transthoracic and transesophageal echocardiography.
    Roldan CA; Gelgand EA; Decker P; Prasad A; Shively BK
    Am J Cardiol; 2002 Dec; 90(11):1269-73. PubMed ID: 12450616
    [No Abstract]   [Full Text] [Related]  

  • 17. Collagen biosynthesis in normal and abnormal human heart valves.
    Henney AM; Parker DJ; Davies MJ
    Cardiovasc Res; 1982 Nov; 16(11):624-30. PubMed ID: 7168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The longitudinal effects of fenfluramine-phentermine use.
    Fleming RM; Boyd LB
    Angiology; 2007; 58(3):353-9. PubMed ID: 17626991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.